RxDoctor Payments Data

Nathan Ullom, DPM

Podiatrist · Mount Vernon, WANPI 1568777175

Payments from drug & device makers

What this record shows

12 manufacturers reported payments, led by Paragon 28, Inc. at 38.4% of the total.

$2,817in general payments, 2019–2025

Across 41 payments — averaging $68.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$1K
  • Arthrex$600
  • Stryker$558
  • Paladin Technology Solutions$424
  • Kerecis Limited$27
  • Smith+Nephew$25
  • plus $101 from 6 others

What the payments were for

  • Travel & lodging$1,22143%
  • Food & beverage$1,59557%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Paragon 28, Inc.8$1,082
Arthrex7$600
Stryker(2 entities)11$558
Paladin Technology Solutions7$424
Kerecis Limited1$27
Smith+Nephew1$25
Heron Therapeutics, Inc.1$21
Aroa Biosurgery Incorporated1$20
Treace Medical Concepts, Inc.1$19
Paratek Pharmaceuticals, Inc.1$18
Bioventus LLC1$15
Medela LLC1$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,817 in reported general payments places this provider in the 75th percentile of 134 podiatrist providers in Washington.

See all podiatrist providers in Washington

Medicare billing

Part B allowed, 2024
$195,577
Medicare patients
535
Services billed
2,804

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole12$372
Cephalexin36$119
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$51

Paid to pharmacies, not to this prescriber.

Other podiatrist in Mount Vernon

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →